What is Carrier Screening?

Carrier screening, usually done before or during a pregnancy,
is a genetic test used to determine if you carry a gene
for certain genetic disorders.

Why should you Consider Carrier Screening?

Carriers of a gene mutation are usually healthy and show no symptoms.
Most people do not know they are a carrier of an inherited genetic disorder until they have a child with the disease. Carrier screening can give you information about your reproductive risk and your chances of having a child with a genetic disorder.

QUICK FACTS ABOUT GENE MUTATION CARRIERS

About 1 in 4

people are carriers for at least one disorder.2

1 in 20

people are carriers for multiple disorders.2

88%

of the carriers had no previous family history.3

1 in 240

couples have increased risk of having a child with a disorder.3

Who should Consider Carrier Screening?

Cordlife carrier screening test can provide important information for people who:
Testing can be carried out either before or during pregnancy (before the 14th week).
If you are already pregnant, your reproductive partner can be tested together.

ODDS OF CONCEIVING AN AFFECTED CHILD

25%
chance

of having an affected child
if you and your spouse are carriers
of the same genetic disorder.

50%
chance

of having an affected son
if the mother is a carrier of an
X-linked (or sex-linked) disorder.

Benefits of Carrier Screening

You and your partner only need to do
carrier screening once in your lifetime.
If you are a carrier and have a new partner,
carrier screening is recommended for
the new partner.
Request Information

CARRIER SCREENING CAN HELP COUPLES
MAKE INFORMED FAMILY PLANNING DECISIONS

If the screening results are positive, the couple can:

Why Choose Cordlife Carrier Screening?

Detects more than 9,000 mutations
associated with 155 recessive genetic disorders,
one of the most comprehensive, accurate and affordable
pre-pregnancy screening tests in the market.

Talk to your obstetrician
or gynaecologist about
Cordlife Carrier Screening today.

Get tested

Need more information?

Contact us

Reference:

1. Committee Opinion No. 690. American College of Obstetricians and Gynecologists. (2017) Obstet Gynecol.129:e35–40.
2. Lazarin GA, Haque IS, Nazareth S, et al. An empirical estimate of carrier frequencies for 400+ causal Mendelian variants: results from an ethnically diverse clinical sample of 23,453 individuals. Genet Med. 2013;15(3):178-186.
3. Archibald AD, Smith MJ, Burgess T, et al. Reproductive genetic carrier screening for cystic fibrosis, fragile X syndrome, and spinal muscular atrophy in Australia; outcomes of 12,000 tests. Genet Med. 2018;20(5)513-523.

Disclaimer

Information contained herein this site is not meant to substitute qualified medical advice and is for reference only. If the test result returns as positive for a mutation, any patient treatment plans should only be undertaken by or in consultation with a qualified healthcare professional. Further, confirmatory or diagnostic testing may be needed for final diagnosis of any condition. Cordlife and its testing partner recommend that non-directive genetic counselling and guidance should always be provided to patients prior to undertaking any genetic testing and when reviewing results with the patient. Accuracy of genetic testing may be affected by certain clinical factors. Therefore, test results should always be interpreted in the context of other clinical and family information of the patient. Informed consent should always be obtained from the patient prior to testing.